Results 191 to 200 of about 48,564 (222)

The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann-Pick Disease: A Comprehensive Review. [PDF]

open access: yesBiomolecules
Tirelli C   +10 more
europepmc   +1 more source

Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale. [PDF]

open access: yesMol Genet Metab Rep
Mengel E   +22 more
europepmc   +1 more source

Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium

Nature Medicine, 2008
Emyr Lloyd-Evans   +9 more
semanticscholar   +3 more sources

Niemann-Pick Disease, Type C: Diagnosis, Management and Disease-Targeted Therapies in Development.

Seminars in Pediatric Neurology, 2021
Niemann-Pick disease, type C (NPC) is a highly heterogeneous rare neurovisceral storage disease with early infantile, late infantile, juvenile and adult onset forms, and relentlessly progressive neurodegeneration leading to death.
E. Berry-Kravis
semanticscholar   +1 more source

Trial of N-Acetyl-l-Leucine in Niemann-Pick Disease Type C.

New England Journal of Medicine
BACKGROUND Niemann-Pick disease type C is a rare lysosomal storage disorder. We evaluated the safety and efficacy of N-acetyl-l-leucine (NALL), an agent that potentially ameliorates lysosomal and metabolic dysfunction, for the treatment of Niemann-Pick ...
T. Bremova-Ertl   +21 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy